Abstract
Clinical characteristics were compared between hypertensive patients with and without heart failure in the absence of reduced ejection fraction (EF) to gain insights into the effects of renal insufficiency on the prevalence of diastolic heart failure. Study subjects consisted of 691 hypertensive patients with an EF > 40%. Patients with serum creatinine >2.5 mg/dL were excluded from the study. The Framingham heart failure criteria were met by 198 patients, and competing risks of the prevalence of heart failure were analyzed. The multiple logistic regression analysis revealed that obesity, female gender, creatinine clearance (CCr), and a ratio of transmitral E velocity to early diastolic mitral annular velocity (E/E′)>15 were independently associated with the prevalence of heart failure with preserved EF. Patients with 60≤CCr<90 mL/min represented higher E/E′ ratio and lower E′ velocity than the patients with CCr≥90 mL/min, although there was no difference in the prevalence of heart failure between the two groups. These indices were not different between the patients with 60≤CCr<90 mL/min and CCr<60 mL/min, although the prevalence of heart failure was higher in the patients with CCr<60 mL/min. The hemoglobin concentration was significantly decreased and the brachial-ankle pulse wave velocity was significantly elevated in patients with CCr<60 mL/min. Thus, progressive left ventricular diastolic dysfunction and renal insufficiency are competing risks of the prevalence of diastolic heart failure in hypertensive patients. Renal insufficiency may exert its effects through the modulation of extracardiac factors such as anemia and arterial stiffening rather than through the promotion of diastolic dysfunction.
Similar content being viewed by others
Article PDF
References
Senni M, Tribouilloy CM, Rodeheffer RJ, et al: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282–2289.
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D : Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948–1955.
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM : Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251–259.
Hillege HL, Nitsch D, Pfeffer MA, et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671–678.
Shulman NB, Ford CE, Hall WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 ( Suppl): I80–I93.
Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S : Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629–636.
Ruilope LM, Salvetti A, Jamerson K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218–225.
Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154–2169.
Yusuf S, Pfeffer MA, Swedberg K, et al: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777–781.
Cleland JGF, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J : The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338–2345.
The J-DHF Program Committee: Rationale and Design of a Randomized Trial to Assess the Effects of Beta-Blocker in Diastolic Heart Failure: Japanese Diastolic Heart Failure Study (J-DHF). J Card Fail 2005; 11: 542–547.
Janardhanan R, Daley WL, Naqvi TZ, et al: Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension. Am Heart J 2006; 152: 246–252.
Maurer MS, Burkhoff D, Fried LP, Gottdiener J, King DL, Kitzman DW : Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol 2007; 49: 972–981.
Yamaguchi H, Yoshida J, Yamamoto K, et al: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55–60.
Quinones MA, Waggoner AD, Reduto LA, et al: A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981; 64: 744–753.
Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440–1463.
Takeda Y, Sakata Y, Mano T, et al: Noninvasive assessment of diastolic function in subjects with preserved left ventricular ejection fraction: usefulness of color kinetic imaging. J Card Fail 2008; 14: 569–576.
Hasegawa S, Yamamoto K, Sakata Y, et al: Effects of cardiac energy efficiency in diastolic heart failure: assessment with positron emission tomography with 11C-acetate. Hypertens Res 2008; 31: 1157–1162.
Kasner M, Westermann D, Steendijk P, et al: Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 2007; 116: 637–647.
Ommen SR, Nishimura RA, Appleton CP, et al: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000; 102: 1788–1794.
Geske JB, Sorajja P, Nishimura RA, Ommen SR : Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 2007; 116: 2702–2708.
Yamashina A, Tomiyama H, Arai T, et al: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615–622.
Yufu K, Takahashi N, Hara M, Saikawa T, Yoshimatsu H : Measurement of the brachial-ankle pulse wave velocity and flow-mediated dilatation in young, healthy smokers. Hypertens Res 2007; 30: 607–612.
Klapholz M, Maurer M, Lowe AM, et al: Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction. J Am Coll Cardiol 2004; 43: 1432–1438.
Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS : Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001; 37: 278–285.
Zile MR, Baicu CF, Gaasch WH : Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953–1959.
Masuyama T, Yamamoto K, Sakata Y, et al: Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy. J Am Coll Cardiol 2000; 36: 2333–2338.
van Heerebeek L, Borbely A, Niessen HWM, et al: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113: 1966–1973.
Yamamoto K, Masuyama T, Sakata Y, et al: Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55: 76–82.
Querejeta R, Lopez B, Gonzalez A, et al: Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 2004; 110: 1263–1268.
Verma A, Anavekar NS, Meris A, et al: The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction. J Am Coll Cardiol 2007; 50: 1238–1245.
Brucks S, Little WC, Chao T, et al: Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 2004; 93: 1055–1057.
O'Meara E, Clayton T, McEntegart MB, et al: Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006; 113: 986–994.
Katz AM : The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med 1994; 121: 363–371.
Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359–364.
Lehmann ED : Clinical value of aortic pulse-wave velocity measurement. Lancet 1999; 354: 528–529.
Asmar R, Benetos A, Topouchian J, et al: Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485–490.
Hundley WG, Kitzman DW, Morgan TM, et al: Cardiac–cycle dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001; 38: 796–802.
Hees PS, Fleg JL, Mirza ZA, Ahmed S, Siu CO, Shapiro EP : Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine. J Am Coll Cardiol 2006; 47: 1440–1447.
Kenchaiah S, Evans JC, Levy D, et al: Obesity and the risk of heart failire. N Engl J Med 2002; 347: 305–313.
Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC : Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43: 1439–1444.
Kenchaiah S, Pocock SJ, Wang D, et al: Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program. Circulation 2007; 116: 627–636.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nishio, M., Sakata, Y., Mano, T. et al. Difference of Clinical Characteristics between Hypertensive Patients with and without Diastolic Heart Failure: The Roles of Diastolic Dysfunction and Renal Insufficiency. Hypertens Res 31, 1865–1872 (2008). https://doi.org/10.1291/hypres.31.1865
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.1865
Keywords
This article is cited by
-
Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD
BMC Nephrology (2018)
-
The Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function and Atherosclerosis in Japanese Patients with Mild-to-Moderate Hypertension (J-ELAN) study
Hypertension Research (2011)
-
Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: The Japanese Aortic Stenosis Study (JASS) Retrospective Analysis
Hypertension Research (2010)